Organ Transplant Diagnostics Market to be Dominated by Increasing Number of Organ Donors Across The World through 2028
Growing technological advancements in transplant
technology and growing public awareness about organ donation and
transplantation are the major drivers of the global organ transplant
diagnostics market.
According to TechSci Research report, “Global
Organ Transplant Diagnostics Market –Industry Size, Share, Trends, Opportunity,
and Forecast, 2018-2028”, the global organ transplant diagnostics
market is anticipated to register a high CAGR during the forecast period. This
can be ascribed to improvement in healthcare infrastructure of various
countries with every passing year.
Increase in donors of various vital organs across
the world is propelling the growth of the global organ transplant diagnostics
market during the forecast period. Kidney and liver are the two major organs
which are donated the most among various parts of the world. According to
Global Observatory on Donation and Transplantation (GODT) in 2020, top five
countries with the highest number of deceased organ donors per million
population were Spain, Croatia, Belgium, France, and United States of
America. According to the data presented by Statista on The Global Gulf
in Organ Donation Rates in 2022, it has been reported that Spain and United
States of America have accounted for 38% donors per million population across
the world, followed by Portugal with 24.8% donors, France with 23.2% donors, UK
with 18.4% donors, and so on. However, certain diagnostic tests are
mandatory to be performed with both organ donor and recipient before organ
transplant procedure which is expected to drive the growth of the global organ
transplant diagnostics market during the forecast period. Significant
advancements in transplant technology over recent years have also led to the
rise in success rate of organ transplants. One significant development is the
use of next-generation sequencing (NGS) technology in organ transplant
diagnostics. NGS can be used to analyze the genetic makeup of both the donor
and the recipient, allowing doctors to better match organs and reduce the risk
of rejection. Additionally, NGS can be used to detect infections and monitor
the immune system, which can help doctors detect and manage post-transplant
complications. Another important advancement is the use of non-invasive
diagnostic tools, such as liquid biopsies and breath tests. These tests can
detect organ rejection and other complications without the need for invasive
procedures, which can reduce the risk of complications and improve patient
outcomes. Moreover, several advanced technologies adopted by healthcare
professionals to improve the efficiency of organ transplant procedures are expected
to bolster the growth of the global organ transplant diagnostics market during
the forecast period. Furthermore, growing awareness among people related organ
transplantations by organization of various campaigns and health awareness
programs are also expected to drive the growth of the global organ transplant
diagnostics market during the forecast period. The availability of highly
qualified healthcare professionals around the world and the establishment of
well-equipped hospitals and medical centers across the world are significant
factors driving the growth of the global organ transplant diagnostics market.
Moreover, enhancement in medical facilities and improvement in healthcare
infrastructure across the world are expected to increase the demand for organ
transplant diagnostics during the forecast period.
However, the high procedural cost of NGS and
PCR-based diagnostic assays, along with lack of knowledge dissemination and
reluctance toward organ transplants among people, are expected to slow down the
growth of the market in the coming years.
Browse over 25 market data Figures and
spread through 91 Pages and an in-depth TOC on "Global
Organ Transplant Diagnostics Market”
The global organ transplant diagnostics market is
segmented based on offering, application, transplant type, technology, end
user, and region.
Based on end user, the market is further divided
into hospitals and transplant centers, academic and research institutions,
reference laboratories, and other end users. Hospitals and transplants centers
are likely to dominate the market during the forecast period. This can be
ascribed to a wide range of expertise provided by the hospitals in pathology
and laboratory diagnostics for conducting screening in pre-transplant and
post-transplant surgeries.
Some of the major companies operating in the global
organ transplant diagnostics market include:
- Abbott Laboratories
- bioMérieux S.A.
- Bio-Rad Laboratories, Inc.
- Eurobio Scientific (Genome Diagnostics B.V.)
- Hoffmann-La Roche Ltd.
- Omixon Inc.
- Thermo Fisher Scientific Inc.
- Quest Diagnostics Incorporated
- CareDx, Inc.
- Core Diagnostics Private Limited
Download Free Sample Report
Customers can also request for 10% free
customization on this report.
“Certain regions such as Asia Pacific are expected
to dominate the global organ transplant diagnostics market during the forecast
period due to growing number of organ transplantations in various developing
countries such as United States. Increase in support provided by the government
to improve healthcare infrastructure of individual country by providing funding
to the companies making innovation in diagnostic facilities are further
expected to register a lucrative growth of the global organ transplant
diagnostics market during the forecast period," said Mr. Karan Chechi,
Research Director with TechSci Research, a research-based global management
consulting firm.
Organ Transplant Diagnostics Market – Global Industry
Size, Share, Trends, Opportunity, and Forecast, 2018-2028 - By Offering (Kits
and Assays, Consumables, and Services), By Application (Donor Testing
(Pre-transplantation testing (Histocompatibility Testing, Blood Profiling
Testing, and Other Testing), Post-transplantation testing (Post-Infection
Testing, Risk of Disorder Testing, and Other Testing)), Recipient Testing
(Pre-transplantation testing (Histocompatibility Testing, Blood Profiling
Testing, and Other Testing), Post-transplantation Testing (Post-Infection
Testing, Risk of Disorder Testing, and Other Testing)), By Transplant Type
(Solid Organ Transplant (Kidney, Liver, Lung, Pancreas, and Other Organs
Transplant), Stem Cell Transplant), By Technology (Molecular Technologies (PCR,
Sanger Sequencing, Next-Generation Sequencing (NGS), Other Molecular
Technologies), Non-molecular Technologies (Serology, Flow Cytometry), Other
Technologies), By End User (Hospitals and Transplant Centers, Academic and
Research Institutions, Reference Laboratories, and Other End Users), and By
Region and Competition”, has evaluated the future growth potential
of the global organ transplant diagnostics market and provides statistics &
information on market size, structure, and future market growth. The report
intends to provide innovative market intelligence and help decision makers take
sound investment decisions. Besides, the report also identifies and analyzes
the emerging trends along with essential drivers, challenges, and opportunities
in the global organ transplant diagnostics market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com